Abbott Laboratories’ sales jump 9.6% in the fiscal third quarter

Abbott Laboratories (NYSE: ABT) published its earnings report for the fiscal third quarter on Wednesday. The company said that its earnings in Q3 came in stronger than what analysts had expected, and expressed confidence that its performance was likely to remain strong in the rest of the year. Shares of the company slid less than 0.5% in premarket trading on Wednesday and tanked another 1.5% on market open. Abbott Laboratories is now trading at £81.51 per share that represents a close to 55% recovery since March, when the stock had touched a year to date low of £48 per share.